RoosterBio and MineBio team up to expand MSC solutions access in China
RoosterBio has entered an exclusive distributor partnership with MineBio Life Sciences to expand access to scalable, research-grade and current good…
All articles by Salong Debbarma
Salong Debbarma
-
-
Halozyme and Vertex sign deal for Hypercon technology
Halozyme Therapeutics' subsidiary Halozyme Hypercon has signed a global exclusive partnership and licence agreement with Vertex Pharmaceuticals for the former's…
-
Apnimed obtains up to $150m in funds for commercial launch of AD109
Apnimed has signed a senior secured credit facility of up to $150m with funds managed by HealthCare Royalty Partners (HCRx)…
-
Neurocrine to acquire Soleno in $2.9bn transaction
Neurocrine Biosciences has signed a definitive agreement to acquire Soleno Therapeutics for $53.00 per share in cash, which represents $2.9bn…
-
Aspect Biosystems receives funding for cellular medicine project
Aspect Biosystems has secured a C$79m($56.6m) investment from the Government of Canada to support a C$280m multi-year project aimed at…
-
MSD secures EC clearance for Keytruda combination therapy for ovarian cancer
Merck (MSD) has received the European Commission (EC) approval for Keytruda (pembrolizumab) along with paclitaxel, with or without bevacizumab, as…
-
Merck KGaA acquires JSR chromatography business
Germany-based Merck KGaA (Merck) has completed its previously announced acquisition of the chromatography business of JSR Life Sciences. This follows…
-
Biocytogen and Sihuan partner to advance new therapeutics for weight loss
Biocytogen has entered a strategic partnership with Sihuan Pharmaceutical to advance new therapeutics across several disease areas, including weight loss.…
-
Telomir seeks FDA approval for Telomir-1 to treat breast cancer
Telomir Pharmaceuticals has submitted an investigational new drug application to the US Food and Drug Administration for Telomir-1 (Telomir-Zn), its…
-
Symeres and Ambagon collaborate for colorectal cancer molecules
Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to address diseases considered…